This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

Document Security Systems Announces Partnership With National Association Of Drug Diversion Investigators

Stocks in this article: DSS

ROCHESTER, N.Y., Oct. 22, 2013 /PRNewswire/ -- Document Security Systems, Inc. (NYSE MKT: DSS; "DSS"), a leading developer and integrator of secure cloud computing and security printing technologies, today announced a partnership with the National Association of Drug Diversion Investigators (NADDI) to help NADDI's members and consumers combat drug diversion and counterfeits.

NADDI is a non-profit organization that facilitates cooperation between law enforcement, healthcare professionals, state regulatory agencies and pharmaceutical manufacturers in the prevention and investigation of prescription drug diversion.  NADDI's objective is to improve its members' ability to investigate and prosecute pharmaceutical drug diversion.

This partnership provides NADDI members access to DSS's AuthentiSuite technologies as part of an initiative to standardize prescription drug authentication for members and customers. NADDI members have never before had access to this type of authentication capability. The AuthentiSite technology can be employed as a tool for investigators or consumers who are looking to verify websites for prescription drug purchases and validate that pharmaceutical product information, lists of authorized suppliers, and other online information comes from the Brand Owner and not an unauthorized or fraudulent source.

AuthentiSite provides true website authentication from a smartphone application. The DSS team will create and distribute an AuthentiSite seal equipped with DSS patented AuthentiGuard ® Prism TM technology for NADDI and its members to implement on their websites.  Using the smartphone application, investigators and consumers alike can scan the seal to verify that a website represents a true, licensed reseller.

Robert Bzdick, President of DSS stated, "We are pleased to be working with NADDI, the nation's most prominent organization linking healthcare regulators, manufacturers and consumers, to offer its members access to our AuthentiSite technology in order to combat drug diversion. This partnership brings the powerhouse of AuthentiSuite technologies into the pharmaceutical world, while opening up future opportunities to build business relationships in this area."

DSS will be attending NADDI's 24 th Annual Conference on November 19 th - The Challenges of Prescription Drug Abuse, Diversion and Counterfeiting for the Community, Law Enforcement and Industry - The Issues and the Fight Back – to discuss the growing number of possibilities AuthentiSite offers.

Charlie Cichon, NADDI Executive Director stated, "We welcome the partnership with DSS and the extraordinary technology of AuthentiSuite, not only at our 24 th Annual Conference in St. Louis, but also through the RxAuthentic link that our members and consumers can access on the NADDI website – www.naddi.org."

About NADDI

The National Association of Drug Diversion Investigators (NADDI) is a non-profit 501(c)(3) organization that facilitates cooperation between law enforcement, healthcare professionals, state regulatory agencies, pharmaceutical manufacturers in the investigation and prevention of prescription drug abuse and diversion. NADDI also sponsors and conducts specialized educational seminars and conferences.

1 of 2

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!

Markets

DOW 18,053.71 +23.50 0.13%
S&P 500 2,088.77 +6.89 0.33%
NASDAQ 4,806.8590 +33.3870 0.70%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs